ArticleJournal of clinical medicine2022

Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer-The CONKO-008 Phase I Investigation.

Jana K Striefler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.